TY - JOUR
T1 - Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas ®)
AU - Kernt, Marcus
AU - Cheuteu, Raoul E.
AU - Cserhati, Sarah
AU - Seidensticker, Florian
AU - Liegl, Raffael G.
AU - Lang, Julian
AU - Haritoglou, Christos
AU - Kampik, Anselm
AU - Ulbig, Michael W.
AU - Neubauer, Aljoscha S.
PY - 2012/2/25
Y1 - 2012/2/25
N2 - Aim: To investigate treatment-related pain and the accuracy of navigated laser photocoagulation in the treatment of clinically significant macular edema. Methods: Focal laser treatment of diabetic macular edema in 54 consecutive patients was digitally planned on fundus images and performed using the navigated laser photocoagulation system Navilas ® (OD-OS GmbH, Teltow, Germany). Treatment-related pain was quantified on a visual analog scale directly after treatment and compared with a matched control group who received conventional laser treatment (n = 46). In addition, for Navilas-treated patients, the accuracy of spot placement on color images was analyzed 1 month after treatment. Results: In total, 5423 laser spots (mean 100 per eye) were analyzed. With navigated treatment, 90% of laser spots were visible on color images, of which 96% were within 100 μm from the target. Eighty percent of the laser spots were placed and visible within the 100 μm target on an intention-to-treat basis for color imaging. Optical coherence topography confirmed that laser effects were limited to the outer retina. Treatment-related pain following navigated laser photocoagulation was significantly lower than that of conventional laser treatment (1.6 vs 4.4 on a visual analog scale, P < 0.001). Conclusion: Navigated laser effects could be visualized to a high percentage on post-treatment color images, and their location showed a high concordance to targeted areas. Patients reported that treatment-related pain following Navilas laser photocoagulation was significantly lower than pain following conventional laser treatment.
AB - Aim: To investigate treatment-related pain and the accuracy of navigated laser photocoagulation in the treatment of clinically significant macular edema. Methods: Focal laser treatment of diabetic macular edema in 54 consecutive patients was digitally planned on fundus images and performed using the navigated laser photocoagulation system Navilas ® (OD-OS GmbH, Teltow, Germany). Treatment-related pain was quantified on a visual analog scale directly after treatment and compared with a matched control group who received conventional laser treatment (n = 46). In addition, for Navilas-treated patients, the accuracy of spot placement on color images was analyzed 1 month after treatment. Results: In total, 5423 laser spots (mean 100 per eye) were analyzed. With navigated treatment, 90% of laser spots were visible on color images, of which 96% were within 100 μm from the target. Eighty percent of the laser spots were placed and visible within the 100 μm target on an intention-to-treat basis for color imaging. Optical coherence topography confirmed that laser effects were limited to the outer retina. Treatment-related pain following navigated laser photocoagulation was significantly lower than that of conventional laser treatment (1.6 vs 4.4 on a visual analog scale, P < 0.001). Conclusion: Navigated laser effects could be visualized to a high percentage on post-treatment color images, and their location showed a high concordance to targeted areas. Patients reported that treatment-related pain following Navilas laser photocoagulation was significantly lower than pain following conventional laser treatment.
KW - Diabetes
KW - Diabetic retinopathy
KW - Navigated laser therapy
KW - Pattern laser
UR - http://www.scopus.com/inward/record.url?scp=84857778924&partnerID=8YFLogxK
U2 - 10.2147/OPTH.S27859
DO - 10.2147/OPTH.S27859
M3 - Article
AN - SCOPUS:84857778924
SN - 1177-5467
VL - 6
SP - 289
EP - 296
JO - Clinical Ophthalmology
JF - Clinical Ophthalmology
IS - 1
ER -